Modern cold calling best practices for 2026 for healthcare and life sciences in emerging markets

This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in emerging markets. In this market, emerging-market buyers reward patient capital, currency-aware pricing, and a real local operating footprint, so the way you install modern cold calling has to be shaped to that reality from day one.

Best practices for modern cold calling have shifted. The 2022 playbook does not survive the current buyer environment. This is the update.

Best practice one: fewer accounts, sharper triggers. One connect on the phone beats 40 emails on the right day, and generic coverage is now negative signal.

Best practice two: publish connects per hour on ICP dials weekly. If leadership does not see the number, the model quietly drifts.

Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in emerging markets it is compounded by the fact that operating footprint and pricing fit, not brand awareness is what actually gates growth. Modern cold calling is only useful here when it is pointed at both constraints at once.

Best practice three: separate the sending infrastructure from the primary brand. Deliverability is a strategic asset.

Best practice four: name a single owner. Committees produce compromise; owners produce numbers.

Best practice five: pre-write kill criteria. A stated failure threshold is what prevents the sunk-cost trap.

Best practice six: run monthly retrospectives that are honest about what did not work. Modern cold calling improves faster on failure data than on success data.

Concretely for healthcare and life sciences in emerging markets: the healthcare teams that install this get past procurement instead of dying in it, and the teams that install this early own the category before Western vendors even show up. That is the reason it is worth installing modern cold calling deliberately for this market rather than importing a playbook designed for somewhere else.